Pillar Biosciences Partners with AstraZeneca to Help Accelerate Access to Liquid Biopsy Testing
Partnership aims to make liquid biopsy tumor profiling more accessible to local laboratories, clinicians and patients through rapid, affordable, kitted NGS testing solutions.
| Ticker |
Sentiment |
Impact |
|
AZN
|
Somewhat Bullish
|
18 %
|
|
ILMN
|
Neutral
|
6 %
|
